Iron Status of Non-anemic Pregnant Women in First Trimester
Establishment of Reference Intervals for Iron Test Panel for Pregnant Women at Hung Vuong Hospital
Hung Vuong Hospital
600 participants
Mar 12, 2025
OBSERVATIONAL
Conditions
Summary
This cross-sectional study aims to establish reference intervals for iron biomarkers-including serum iron, ferritin, total iron-binding capacity (TIBC), and transferrin saturation (TSAT)-in healthy pregnant women during the first trimester. Additionally, the study will investigate the current prevalence of non-anemic iron deficiency (NAID) in this population. By applying strict inclusion and exclusion criteria to eliminate potential confounding factors, the study seeks to provide a reliable baseline for evaluating iron status and early detection of iron deficiency without anemia among pregnant women.
Eligibility
Inclusion Criteria5
- Pregnant women attending antenatal care, carrying a single live fetus.
- Systolic blood pressure at the time of examination \< 140 mmHg.
- Diastolic blood pressure at the time of examination \< 90 mmHg.
- Body temperature at the time of examination between \>35°C and \<37.5°C.
- Hemoglobin ≥ 11 g/dL
Exclusion Criteria3
- History of diabetes mellitus, hypertension, hemoglobinopathies, leukemia, non-hematologic cancers, systemic lupus erythematosus, Gastrointestinal diseases (Celiac disease, Crohn's disease and ulcerative colitis, Gastric diseases or prior gastrointestinal surgery, Irritable bowel syndrome, etc).
- Currently on gastric acid-suppressing medications: Proton pump inhibitors (e.g., Omeprazole, Lansoprazole, Esomeprazole...), H2 receptor antagonists (e.g., Ranitidine, Famotidine, Cimetidine...), Positive screening for Treponema pallidum, HBsAg, or HIV.
- Use of stimulants or tobacco smoking.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06990373